Dual HER2 Blockade in Neoadjuvant Treatment of HER2+ Breast Cancer: A Meta-Analysis and Review

BACKGROUND: To investigate the pathologic complete response (pCR) rates of dual human epidermal growth factor receptor 2 (HER2) blockade in a neoadjuvant setting for HER2+ breast cancer. METHODS: We searched randomized clinical trials (RCTs) using dual HER2 blockade in a neoadjuvant setting for HER2...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chaokun, Chen, Jing, Xu, Xiangyun, Hu, Xiaochen, Kong, Dejiu, Liang, Gaofeng, Wang, Xinshuai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534077/
https://www.ncbi.nlm.nih.gov/pubmed/32990165
http://dx.doi.org/10.1177/1533033820960721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534077/
https://www.ncbi.nlm.nih.gov/pubmed/32990165
http://dx.doi.org/10.1177/1533033820960721

Ejemplares similares